Cellectis (CLLS) Net Margin (2015 - 2026)

Cellectis (CLLS) posted quarterly Net Margin of 0.0% for Q1 2026, little changed year-over-year from 0.0% in Q1 2025, and down 52.39% quarter-over-quarter from 0.0% in Q4 2025.

Cellectis (CLLS) Net Margin (2015 - 2026) Analysis & Trends

Cellectis' Net Margin history runs 12 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • In Q1 2026, Net Margin changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 32.88% (up 4374.0% YoY), while the FY2025 annual figure was 0.0%, up 7469.0% from the prior year.
  • Net Margin for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
  • The five-year high for Net Margin was 124.62% in Q1 2024, with the low at 21635.97% in Q1 2023.
  • The 5-year median for Net Margin is 167.34% (2022), against an average of 3541.98%.
  • The sharpest annual moves came in 2023 and 2024: Net Margin slumped 1971939 bps in 2023, then soared 2176060 bps in 2024.
  • Cellectis' Net Margin stood at 167.34% in 2022, then sank by 186 bps to 479.25% in 2023, then soared by 106 bps to 28.99% in 2024, then plunged by 100 bps to 0.0% in 2025, then plunged by 52 bps to 0.0% in 2026.
  • Business Quant data shows CLLS's Net Margin at 0.0% in Q1 2026, 0.0% in Q4 2025, and 1.67% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 Cellectis 306.61 Mn 120.95 Mn - 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 1.67%
Jun 30, 2025 -141.92%
Mar 31, 2025 0.00%
Dec 31, 2024 28.99%
Sep 30, 2024 -142.32%
Jun 30, 2024 -313.48%
Mar 31, 2024 124.62%
Dec 31, 2023 -479.25%
Sep 30, 2023 -11,278.71%
Jun 30, 2023 -6,576.97%
Mar 31, 2023 -21,635.97%
Dec 31, 2022 -167.34%
Sep 30, 2022 -16,266.86%
Jun 30, 2022 -1,449.58%
Mar 31, 2022 -1,916.58%
Dec 31, 2021 -243.59%
Sep 30, 2021 -450.11%
Jun 30, 2021 -357.19%